Evidence map›Paper›PMID 31771286›Full record

ArticleMarine drugs2019

Fucoidan from

Yu Chen, Xuenan Li, Xiaoshuang Gan, Junmei Qi, Biao Che, Meiling Tai, Shuang Gao, Wengang Zhao, Nuo Xu, Zhenlin Hu

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Acta biochimica et biophysica Sinica · 2024
    Article
  4. The Effect of Polynucleotide-Hyaluronic Acid Hydrogel in the Recovery After Mechanical Skin Barrier Disruption.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Protective effects of fucoidan purified fromAnnals of translational medicine · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Yu ChenCollege of Life and Environmental Sciences, Wenzhou University, Wenzhou 325035, China.
Xuenan LiInstitute of Life Sciences, Wen Zhou University, Wenzhou 325035, China.
Xiaoshuang GanInfinitus (China) Company Ltd, Guangzhou 510000, China.
Junmei QiCollege of Life and Environmental Sciences, Wenzhou University, Wenzhou 325035, China.
Biao CheInfinitus (China) Company Ltd, Guangzhou 510000, China.
Meiling TaiInfinitus (China) Company Ltd, Guangzhou 510000, China.
Shuang GaoInstitute of Life Sciences, Wen Zhou University, Wenzhou 325035, China.
Wengang ZhaoInstitute of Life Sciences, Wen Zhou University, Wenzhou 325035, China.
Nuo XuCollege of Life and Environmental Sciences, Wenzhou University, Wenzhou 325035, China.
Zhenlin HuInstitute of Life Sciences, Wen Zhou University, Wenzhou 325035, China.
Wenzhou University · CNInfinitus (China) · CN

Funding

National Natural Science Foundation of China 81903736
6 · The paper itself

Abstract

The epidermal barrier acts as a line of defense against external agents as well as helps to maintain body homeostasis. The calcium concentration gradient across the epidermal barrier is closely related to the proliferation and differentiation of keratinocytes (KCs), and the regulation of these two processes is the key to the repair of epidermal barrier disruption. In the present study, we found that fucoidan from

Indexed as

Administration, CutaneousAnimalsCalciumCell DifferentiationCell LineCell ProliferationDisease Models, AnimalEpidermisHumansHydrogelsKeratinocytesMaleMicePermeabilityPolysaccharidesReceptors, Calcium-SensingCalciumCASR protein, humanCASR protein, mousefucoidanHydrogelsPolysaccharidesReceptors, Calcium-SensingCaSRepidermal barrierERKp38UPF

Identifiers

PMID31771286
PMCPMC6950751
OpenAlexW2989986559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.